Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-28

FDA Approved: INZIRQO — Original Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved INZIRQO, a brand-name hydrochlorothiazide, under ANI Pharmaceuticals' original application.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INZIRQO (Hydrochlorothiazide)

Snippet

ORIG AP for INZIRQO (HYDROCHLOROTHIAZIDE)